✦ LIBER ✦

Complement functional tests for monitoring eculizumab treatment in patients with atypical hemolytic uremic syndrome

✍ Scribed by Cugno, M.; Gualtierotti, R.; Possenti, I.; Testa, S.; Tel, F.; Griffini, S.; Grovetti, E.; Tedeschi, S.; Salardi, S.; Cresseri, D.; Messa, P.; Ardissino, G.

Book ID: 121852328
Publisher: John Wiley and Sons
Year: 2014
Tongue: English
Weight: 291 KB
Volume: 12
Category: Article
ISSN: 1538-7933
DOI: 10.1111/jth.12615

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Neurologic involvement in atypical hemol

Neurologic involvement in atypical hemolytic uremic syndrome and successful treatment with eculizumab

✍ Gulleroglu, Kaan; Fidan, Kibriya; HanÃ§er, Veysel S.; Bayrakci, Umut; Baskin, Es 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 151 KB

Efficacy of eculizumab in a patient with

Efficacy of eculizumab in a patient with factor-H-associated atypical hemolytic uremic syndrome

✍ Anne-Laure Lapeyraque; Véronique Frémeaux-Bacchi; Pierre Robitaille 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 308 KB

Eculizumab for the treatment of two recu

Eculizumab for the treatment of two recurrences of atypical hemolytic uremic syndrome in a kidney allograft

✍ Nada Alachkar; Serena M. Bagnasco; Robert A. Montgomery 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 179 KB

Complement activation during liver trans

Complement activation during liver transplantation has relevance for patients with atypical hemolytic uremic syndrome

✍ Aino Koskinen; Eija Tukiainen; Arno Nordin; Heikki Mäkisalo; Krister Höckerstedt 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 74 KB

Mutations in alternative pathway complem

Mutations in alternative pathway complement proteins in American patients with atypical hemolytic uremic syndrome

✍ Tara K. Maga; Carla J. Nishimura; Amy E. Weaver; Kathy L. Frees; Richard J.H. Sm 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB

Atypical hemolytic uremic syndrome (aHUS) is characterized by acute renal failure, thrombocytopenia and microangiopathic hemolytic anemia, and occurs with an estimated incidence in the USA of 2 per 1,000,000. Disease pathogenesis is related to dysregulation of the alternative pathway (AP) of the com

Immunogenicity of meningococcus C vaccin

Immunogenicity of meningococcus C vaccination in a patient with atypical hemolytic uremic syndrome (aHUS) on eculizumab therapy

✍ Manuela Zlamy; Johannes Hofer; Johannes Elias; Ulrich Vogel; Matthias Frosch; Th 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 270 KB